A conversation with Ron Busby, Sr., President and CEO of the U.S. Black Chambers, Inc. on improving vaccine confidence in communities of color
By Stephen J. Ubl | May 5, 2021
The COVID-19 pandemic exposed and often exacerbated the significant systemic health inequities that underserved communities have faced for many years. Black Americans have been particularly...
Read More
PhRMA member companies share how they are improving clinical trial diversity
By Dr. Freda Lewis-Hall | April 14, 2021
As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial...
Read More
Diversifying clinical trials and fighting disease requires equity and trust
By Rebecca Marklund | April 12, 2021
The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and...
Read More
Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive
By Abigail Lore | March 5, 2021
Last week, PhRMA submitted comments to the United States Patent and Trademark Office (USPTO) in response to a request for comments on the National Strategy for Expanding American Innovation....
Read More
Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen
By Courtney Christian | January 28, 2021
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.
Read More
New report highlights biopharmaceutical industry’s commitment to D&I
By Abigail Lore | December 17, 2020
Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the...
Read More
Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US
By Stephen J. Ubl | December 16, 2020
This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections....
Read More
Sharing rebates can improve access to medicines and increase health equity
By Guest Contributor | September 30, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
PhRMA will continue to advocate for equity within our industry
By Yolanda Hutchins | September 10, 2020
When I first started at PhRMA two and a half years ago, our organization was just starting to talk about how we could increase and activate our commitment to diversity & inclusion (D&I). As senior...
Read More
Three ways the pharmaceutical industry can positively impact health equity
By Guest Contributor | September 1, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
